Home LiteratureArticle Details
PMID: 16160170 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.

Journal of virology ·Vol. 79 ·No. 19 ·2005-10-00 ·Pages 12425-33

Gerlach JT, Ulsenheimer A, Grüner NH, Jung MC, Schraut W, Schirren CA, Heeg M, Scholz S, Witter K, Zahn R, Vogler A, Zachoval R, Pape GR, Diepolder HM

Abstract

The hepatitis C virus (HCV)-specific CD4+ T-cell response against nonstructural proteins is strongly associated with successful viral clearance during acute hepatitis C. To further develop these observations into peptide-based vaccines and clinical immunomonitoring tools like HLA class II tetramers, a detailed characterization of immunodominant CD4+ T-cell epitopes is required. We studied peripheral blood mononuclear cells from 20 patients with acute hepatitis C using 83 overlapping 20-mer peptides covering the NS3 helicase and NS4. Eight peptides were recognized by > or = 40% of patients, and specific CD4+ T-cell clones were obtained for seven of these and three additional, subdominant epitopes. Mapping of minimal stimulatory sequences defined epitopes of 8 to 13 amino acids in length, but optimal T-cell stimulation was observed with 10- to 15-mers. While some epitopes were presented by different HLA molecules, others were presented by only a single HLA class II molecule, which has implications for patient selection in clinical trials of peptide-based immunotherapies. In conclusion, using two different approaches we identified and characterized a set of CD4+ T-cell epitopes in the HCV NS3-NS4 region which are immunodominant in patients achieving transient or persistent viral control. This information allows the construction of a valuable panel of HCV-specific HLA class II tetramers for further study of CD4+ T-cell responses in chronic hepatitis C. The finding of immunodominant epitopes with very constrained HLA restriction has implications for patient selection in clinical trials of peptide-based immunotherapies.

MeSH Terms
Adolescent Adult Alleles Amino Acid Sequence Antigen Presentation CD4-Positive T-Lymphocytes/immunology Female HLA Antigens/genetics,physiology Hepacivirus/immunology Hepatitis C/immunology Humans Immunodominant Epitopes Leukocytes, Mononuclear/immunology Lymphocyte Activation Male Middle Aged Molecular Sequence Data Viral Nonstructural Proteins/immunology
Chemicals
HLA Antigens Immunodominant Epitopes NS3 protein, hepatitis C virus NS4 protein, hepatitis C virus Viral Nonstructural Proteins
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Gerlach J T
Department of Gastroenterology and Hepatology, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland. Tilman.Gerlach@usz.ch
Ulsenheimer A
Grüner N H
Jung M-C
Schraut W
Schirren C-A
Heeg M
Scholz S
Witter K
Zahn R
Vogler A
Zachoval R
Pape G R
Diepolder H M
References (19)
19 references, click to expand
  1. Hepatitis C virus infection in the United States.
    J Hepatol. 1999;31 Suppl 1:88-91 PMID: 10622567
  2. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.
    Gastroenterology. 1999 Oct;117(4):933-41 PMID: 10500077
  3. Clinical significance of hepatitis C virus genotypes and quasispecies.
    Semin Liver Dis. 2000;20(1):103-26 PMID: 10895435
  4. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
    Eur J Immunol. 2001 May;31(5):1438-46 PMID: 11465100
  5. Determinants of viral clearance and persistence during acute hepatitis C virus infection.
    J Exp Med. 2001 Nov 19;194(10):1395-406 PMID: 11714747
  6. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
    Hepatology. 2002 May;35(5):1225-36 PMID: 11981773
  7. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.
    J Virol. 2002 Dec;76(24):12584-95 PMID: 12438584
  8. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.
    Hepatology. 2003 Mar;37(3):577-89 PMID: 12601356
  9. Definition of supertypes for HLA molecules using clustering of specificity matrices.
    Immunogenetics. 2004 Mar;55(12):797-810 PMID: 14963618
  10. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    J Viral Hepat. 2004 Jul;11(4):324-31 PMID: 15230855
  11. Effects of antiviral therapy on the cellular immune response in acute hepatitis C.
    Hepatology. 2004 Jul;40(1):87-97 PMID: 15239090
  12. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
    Hepatology. 1995 Mar;21(3):632-8 PMID: 7875660
  13. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.
    Lancet. 1995 Oct 14;346(8981):1006-7 PMID: 7475549
  14. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
    J Clin Invest. 1996 Aug 1;98(3):706-14 PMID: 8698862
  15. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity.
    Hepatology. 1997 Feb;25(2):449-58 PMID: 9021963
  16. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.
    J Virol. 1997 Aug;71(8):6011-9 PMID: 9223492
  17. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus.
    Int Immunol. 1999 Apr;11(4):577-83 PMID: 10323211
  18. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
    Hepatology. 1999 Oct;30(4):1088-98 PMID: 10498664
  19. Analysis of successful immune responses in persons infected with hepatitis C virus.
    J Exp Med. 2000 May 1;191(9):1499-512 PMID: 10790425
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2005-10-00
Pages
12425-33
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1211510
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com